Metastatic Differentiated Thyroid Gland Carcinoma
2 clinical trials · Condition
◉ Watch Metastatic Differentiated Thyroid Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer (NCT06959641) | Jochen Lorch | 2025-06-06 |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
Track Metastatic Differentiated Thyroid Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.